MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Sponsored by Abiomed, Inc.
Case Report: Impella 2.5™ Support During Complex PCI in a Patient With Recent Acute Systolic Heart Failure and Residual Low Ejection Fraction
By Mark A. Grise, MD; Tyrone J. Collins, MD; and Samir N. Patel, MD
Optical Coherence Reflectometry in Coronary CTOs
A review of the history and emerging role in chronic coronary total occlusions.
By Joseph A. Quash, Jr, MD, and Richard R. Heuser, MD, FACC, FACP, FESC
TAVI: Which Valve for Which Patient?
A review of the technical challenges and optimal valve choices in different clinical and anatomic scenarios.
By Noman Ali, PhD, and Daniel J. Blackman, MD
Improving Patient Outcomes After PCI Without Long-Term, Dual-Antiplatelet Therapy
Advancing the value of stent system technology.
Meril’s Myval Octapro THV Launched in Europe
December 2, 2024—Meril Life Sciences, an India-based company focused on cardiovascular and structural heart solutions, recently announced the launch of its next-generation Myval Octapro transcatheter heart valve (THV), which has received CE Mark approval for transcatheter aortic valve replacement (TAVR).
The State of Transcatheter Mitral Valve Implantation
An examination of the past, present, and future of TMVI data, trials, and devices.
By Ruby Satpathy, MD, FACC, FSCAI; Trinath K. Mishra, MD; and Chhabi Satpathy, MD, FACC, FSCAI
IDE Approved for Trial of Carag’s Transcatheter Bioresorbable Septal Occluder
July 1, 2020—Carag AG, a Switzerland-based medical device company, announced it has received FDA investigational device exemption approval for the Carag bioresorbable septal occluder (CBSO), the company’s transcatheter septal occluder with a bioresorbable, metal-free framework.
Biosensors’ Rise SC Balloon Evaluated in First-in-Human Trial
February 4, 2022—Biosensors International Group, Ltd. announced the enrollment of the first patient in the RISE SC study.
Dyspnea in a Diabetic Patient With Previous TAVR
Moderator: Franz X. Kleber, MDPanel: Finn Gustafsson, MD, PhD, and Felix Mahfoud, MD
Sponsored by ACIST
Ultra-Low Contrast Imaging and PCI
Minimizing contrast volume in angiography and PCI.
By Ziad A. Ali, MD, DPhil
Percutaneous Suture Closure for TAVR
A description of procedural steps and data regarding percutaneous access management for transcatheter aortic valve replacement.
By Creighton Don, MD, and Elizabeth M. Holper, MD, MPH
Improvements in Femoral Access and Closure for TAVR
A focus on early recognition and prompt percutaneous endovascular management of failure of femoral artery percutaneous preclosure.
By Nelson L. Bernardo, MD, and Augusto D. Pichard, MD
Technical Tips for Inserting and Positioning the Impella Device
A practical guide to Impella insertion, repositioning, and management of related complications.
By Luca Baldetti, MD; Alessandro Beneduce, MD; Alaide Chieffo, MD; and Anna Mara Scandroglio, MD
Pulmonary Arteriovenous Malformations and Coronary Artery Fistulas
Pulmonary arteriovenous malformations (PAVMs) and coronary artery fistulas (CAFs) are infrequent clinical problems but can potentially cause significant morbidity and mortality.
Utility of CT Coronary Angiography for Planning CTO Intervention
CTCA shows promise as an important modality in treating this challenging subset.
By Marc C. Newell, MD, and Robert S. Schwartz, MD
Neovasc’s Reducer System Receives National Reimbursement in France to Treat Refractory Angina
November 30, 2021—Neovasc Inc. announced that the company’s Reducer system has been granted Prise en Charge Transitoire (PECT) reimbursement in France by the national health authority, Haute Autoritté de Santé (HAS).
An Interview With Steven L. Goldberg, MD
Dr. Goldberg shares his perspective on the wealth of information coming out of the interventional cardiology field today, as well as his philosophy on patient education.
Current Status of Percutaneous Mitral Repair Using the MitraClip System
Growing experience with this first-in-class device suggests it will have an important role in treating patients with mitral regurgitation.
By Michael J. Rinaldi, MD, FACC, FSCAI; Gale Schwarz, RN, CCRC; and Geoffrey Rose, MD, FACC, FASE
Study Finds Rising Death Rates From Pulmonary Embolism
August 17, 2020—The American Heart Association (AHA) announced that after approximately a decade of steady decline, the mortality rate for patients with pulmonary embolism (PE) has risen during the past decade.
Echocardiographic Aortic Annulus Sizing for TAVR
Can it be done, and is this approach reliable and accurate?
By Nishath Quader, MD
